Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial, looking exclusively at women.
Medtronic has more positive TAVR data from women-focused study massdevice.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from massdevice.com Daily Mail and Mail on Sunday newspapers.